---
title: "Tempest Therapeutics (TPST.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TPST.US/norm.md"
symbol: "TPST.US"
name: "Tempest Therapeutics"
parent: "https://longbridge.com/en/quote/TPST.US.md"
datetime: "2026-05-21T17:30:26.807Z"
locales:
  - [en](https://longbridge.com/en/quote/TPST.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TPST.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TPST.US/norm.md)
---

# Tempest Therapeutics (TPST.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -2.53 | -0.8194 | -0.7907 | -2.07 | -3.16 |
| ROE | -2958.18% | -247.18% | -174.15% | -301.01% | -287.12% |
| Revenue | - | - | - | - | - |
| Net income | -27.70M | -4.02M | -3.51M | -7.87M | -10.86M |
| Operating income | -5.54M | -4.08M | -3.60M | -7.97M | -10.94M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 10.75M | 16.93M | 17.13M | 24.48M | 32.16M |
| Leverage | 13.08 | 2.54 | 2.70 | 2.50 | 2.89 |
| BVPS | 0.0573 | 1.35 | 1.43 | 2.20 | 3.16 |
| Turnover | - | - | - | - | - |
| Cash & STI | 1.80M | 7.71M | 7.51M | 14.28M | 21.51M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 7.79M | 8.14M | 8.51M | 8.85M | 9.19M |
| Net debt | 6.05M | 434000.00 | 891000.00 | -5.62M | -8.41M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -7.60M | -3.57M | -6.78M | -8.43M | -8.04M |
| Investing CF | - | - | - | - | - |
| Financing CF | 1.70M | 3.77M | 13000.00 | 1.20M | -721000.00 |
| Free CF | -3.53M | -2.14M | -5.55M | -5.61M | -4.17M |
| OCF coverage | - | - | - | -199.41% | -365.61% |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |